Optiver Holding
NVCR icon

Optiver Holding’s NovoCure NVCR Stock Holding History

Optiver Holding’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.59K Buy
237
+172
+265% +$2.6K ﹤0.01% 2115
2026
Q1 		$708 Buy
+65
New +$812 ﹤0.01% 2115
2025
Q4 		– Sell
-626
Closed -$8.09K – 2819
2025
Q3 		$8.09K Buy
626
+480
+329% +$6.41K ﹤0.01% 1428
2025
Q2 		$2.6K Buy
146
+108
+284% +$1.88K ﹤0.01% 1323
2025
Q1 		$677 Buy
+38
New +$863 ﹤0.01% 1294

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Optiver Holding's NVCR Position: Q2 2026 in Review

Optiver Holding increased its NovoCure (NVCR) stake by 265% in Q2 2026, buying an estimated $2.6K and bringing the position to 237 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

Optiver Holding first reported a position in NVCR in Q1 2025 and has held it in 5 quarters since. The position peaked at $8.09K in Q3 2025. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Optiver Holding held 237 shares of NovoCure worth $3.59K as of Q2 2026.
  • Optiver Holding bought 172 NovoCure shares in Q2 2026, an estimated $2.6K.
  • NovoCure made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2115 holding.
  • Optiver Holding first reported a position in NovoCure in Q1 2025 and has held it in 5 quarters since.
  • Optiver Holding's NovoCure position peaked at $8.09K in Q3 2025.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.